Myriad decision applied in diagnostic claims case
06-11-2013
ACLU files Supreme Court brief in Myriad case
29-01-2013
Myriad: Keeping a low profile
01-12-2012
The US Supreme Court has ruled that isolated human DNA is not patent eligible and has struck down patents owned by biotech company Myriad, ending a long-running and controversial case.
If you have already subscribed please login.
If you have any technical issues please email tech support.
myriad genetics, aclu, us supreme court, gene patents, isolated DNA patents, BRCA1, BRCA2
